NDC 54771-1614 - Depo-Medrol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54771-1614
- Package NDCs from labels
- 54771-1614-1
- Manufacturer
- Zoetis Inc.
- Effective date
- 2026-03-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Depo-Medrol ® | Zoetis Inc. | 2026-03-27 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54771-1614-1 | Depo-Medrol | 5 mL in 1 VIAL | INJECTION, SUSPENSION | 5 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54771-1614 | DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) INJECTION, SUSPENSION [ZOETIS INC.] | 5 | 1 package rows | 20211209_9f1b7ce6-0733-47fa-8a14-a29a4d026992.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| methylprednisolone acetate | ACTIVE INGREDIENT | 43502P7F0P | DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) INJECTION, SUSPENSION [ZOETIS INC.] | 1 | |
| methylprednisolone | ACTIVE MOIETY | X4W7ZR7023 | DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) INJECTION, SUSPENSION [ZOETIS INC.] | 1 | |
| polyethylene glycol 3350 | INACTIVE INGREDIENT | G2M7P15E5P | DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) INJECTION, SUSPENSION [ZOETIS INC.] | 1 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) INJECTION, SUSPENSION [ZOETIS INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Saline | NASAL | PUBLIX SUPER MARKETS, INC | 19841567-9511-43d6-ba4e-d1e1bd3481a4 | 2026-10-22 | Warnings | 451W47IQ8X |
| clearlax | POLYETHYLENE GLYCOL 3350 | Publix Super Markets Inc | ee30489a-8683-4403-8f85-76434242663c | 2026-10-13 | Warnings | G2M7P15E5P |
| Polyethylene glycol 3350 | POLYETHYLENE GLYCOL 3350 | Cardinal Health 107, LLC | 2f5c975f-0d35-4f68-a27c-28af9a898733 | 2026-10-13 | Warnings | G2M7P15E5P |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| good sense clearlax | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | 9858edef-cdb2-4ac4-8e4b-ba0720a24e41 | 2026-10-09 | Warnings | G2M7P15E5P |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X G2M7P15E5P |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X G2M7P15E5P |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X G2M7P15E5P |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| MEIJER Saline | NASAL | MEIJER | a5c6d800-078a-4b66-9d4c-cf3c53f5c138 | 2026-10-05 | Warnings | 451W47IQ8X |
| Personal CARE Saline Nasal | SODIUM CHLORIDE | Delta Brands Inc. | 5ccaf7a1-6891-eac4-e063-6294a90a829f | 2026-10-02 | Warnings | 451W47IQ8X |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Aurohealth LLC | 2a3ef673-418e-45d2-b17b-50d28e172333 | 2026-09-30 | Warnings | G2M7P15E5P |
| Good Neighbor Pharmacy ClearLax | POLYETHYLENE GLYCOL 3350 | Amerisource Bergen | 4f2d3ef2-5097-4653-8dab-de5ba1fb9c41 | 2026-09-28 | Warnings | G2M7P15E5P |
| berkley and jensen clearlax | POLYETHYLENE GLYCOL 3350 | BJWC | f9eb9023-c83b-49b4-af82-d8344ffa46c3 | 2026-09-28 | Warnings | G2M7P15E5P |
| clear lax | POLYETHYLENE GLYCOL 3350 | H E B | bd16827b-5e6a-4fa7-bc2e-c9a05e1e2dab | 2026-09-28 | Warnings | G2M7P15E5P |
| Dextrose And Sodium Chloride | DEXTROSE AND SODIUM CHLORIDE | B. Braun Medical Inc. | 8e6569ce-9714-497f-a94b-c6975c1d76f6 | 2026-09-28 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.